Upstate Active Clinical Trials
Study Title:Comparative Study of the Diagnostic Accuracy of Scintimammography (Technetium 99m-Sestamibi and Fluorine 18-FDG PET Scintigraphic Imaging) and Magnetic Resonance Imaging in Identifying Malignant Breast Lesions, in Subjects with Breast Abnormalities.
What is the purpose of the study?Due to x-ray mammograms being difficult to interpret, this study will determine the diagnostic accuracy of breast Magnetic Resonance Imaging and Nuclear Medicine (including) PET imaging.
Upstate Institutional Review Board (IRB) Number:264939
Patient Age Group:Adults
Principal Investigator:David H Feiglin, MD
Who is eligible?Difficult to interpret or non-interpretable mammogram (usually due to dense tissue in the breasts).
What is involved if I participate?
- How long is the study?
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
- What tests and procedures are involved?
Nuclear medicine breast imaging, PET scan, magnetic resonance study.
Where will the study take place?SUNY Upstate Medical University,Syracuse, NY
Who can I contact for more information?
Name: Susan A Hemingway